Skip to content
can probiotics help with arthritis can probiotics help with arthritis

Can Probiotics Help Knee Arthritis? New Meta Analysis Links Gut Health to Less Pain and Inflammation

TLDR

A 2026 systematic review and meta analysis of eight randomized controlled trials found that probiotics may modestly improve several symptoms of knee osteoarthritis, including pain and stiffness, while also reducing the inflammatory marker C reactive protein. Importantly, probiotics did not significantly increase adverse events compared with placebo.

However, the evidence is still preliminary. Results varied substantially depending on the probiotic strain, treatment duration, disease severity, and inflammatory status. Physical function did not significantly improve overall, and the researchers emphasized that larger, longer term trials are needed before probiotics can be considered an established treatment for knee osteoarthritis.

The bigger story may be the emerging gut joint axis, the idea that changes in gut bacteria and intestinal inflammation can potentially influence inflammation inside joints.

Can Your Gut Bacteria Affect Knee Pain?

When your knees hurt, your gut probably is not the first place you think to look.

Knee osteoarthritis is usually associated with cartilage breakdown, aging, previous injuries, body weight, inflammation, and mechanical stress on the joint.

All of those factors matter.

But researchers are increasingly investigating another possible contributor:

Your gut microbiome.

The trillions of microorganisms living inside your digestive system influence far more than digestion.

They interact with the immune system, help maintain the intestinal barrier, produce metabolites, and influence inflammatory signaling throughout the body.

Researchers now refer to one potential connection between the intestines and joints as the gut joint axis.

A new systematic review and meta analysis published in Frontiers in Medicine examined whether manipulating that gut environment with probiotics might actually improve symptoms in people with knee osteoarthritis.

The findings are intriguing.

Probiotics appeared to improve some measures of pain and stiffness and reduce systemic inflammation.

But the results also revealed an important lesson:

When it comes to probiotics, the specific strain may matter tremendously.

What Is Knee Osteoarthritis?

Knee osteoarthritis, commonly called knee OA, is a degenerative joint condition involving changes to cartilage, bone, synovial tissue, and other structures inside the knee.

Common symptoms include:

  • Knee pain
  • Joint stiffness
  • Reduced mobility
  • Difficulty walking or climbing stairs
  • Swelling
  • Reduced physical function

The condition becomes increasingly common with age and can significantly affect quality of life.

Traditional management often includes exercise, weight management when appropriate, physical therapy, pain medications, anti inflammatory medications, injections, and eventually joint replacement in severe cases.

The authors of this new review point out that current treatments have limitations, which has encouraged researchers to investigate additional approaches that may influence the inflammatory processes associated with osteoarthritis.

That is where probiotics enter the conversation.

What Does Your Gut Have to Do With Your Knees?

The gut joint connection revolves largely around inflammation.

Your intestines normally act as a barrier between the contents of your digestive tract and the bloodstream.

When the gut microbiome becomes disrupted, sometimes called dysbiosis, intestinal barrier function may also be affected.

The researchers describe a potential pathway involving bacterial products such as lipopolysaccharide, or LPS.

If bacterial products cross the intestinal barrier, they may activate immune pathways such as Toll like receptor 4 and increase inflammatory molecules including:

  • IL 6
  • TNF alpha
  • IL 1 beta

These inflammatory signals can circulate throughout the body and potentially contribute to inflammation inside joints.

Researchers have also observed differences in the gut microbiomes of people with knee osteoarthritis, including lower levels of certain beneficial bacteria and microbiome patterns associated with disease severity.

This has led to an intriguing hypothesis:

If unhealthy gut bacteria contribute to systemic inflammation, could improving the gut microbiome reduce joint inflammation and pain?

How Might Probiotics Help?

Probiotics are live microorganisms that, when consumed in appropriate amounts, may provide health benefits.

Depending on the strain, probiotics may potentially:

  • Support the intestinal barrier
  • Compete with harmful microorganisms
  • Influence immune function
  • Reduce inflammatory signaling
  • Increase production of beneficial short chain fatty acids
  • Influence gut derived metabolites

The authors note that certain Lactobacillus and Bifidobacterium strains may decrease intestinal endotoxin exposure and systemic inflammation.

Other strains may influence inflammatory pathways such as NF kappa B, a signaling pathway involved in the production of inflammatory cytokines and cartilage degrading enzymes.

That gives probiotics a biologically plausible pathway for affecting osteoarthritis without acting directly inside the knee.

The New Meta Analysis

Researchers searched both English and Chinese scientific databases for randomized controlled trials examining probiotics in people with knee osteoarthritis.

After screening 200 records, they ultimately included:

8 randomized controlled trials

The studies lasted between approximately 3 and 6 months and evaluated several different probiotic strains and combinations.

Interventions included strains such as:

  • Lactobacillus casei Shirota
  • LatiLactobacillus sakei LB P12
  • Saccharomyces boulardii
  • Bifidobacterium infantis BX 01
  • Bifidobacterium lactis
  • Streptococcus thermophilus TCI633
  • Multi strain probiotic combinations

Some trials used probiotics alone.

Others combined probiotics with treatments such as glucosamine, chondroitin, calcium, or physical therapy, while control groups received the same background treatment without the probiotic.

Researchers examined several outcomes, including:

  • Pain
  • Knee stiffness
  • Physical function
  • WOMAC scores
  • C reactive protein
  • Other inflammatory markers
  • Adverse events

Probiotics Reduced Pain

Pain was one of the clearest positive findings.

Five studies assessed pain using the Visual Analog Scale, commonly called VAS.

When those studies were pooled, probiotics produced a statistically significant reduction in pain compared with control treatment.

The mean difference was:

Minus 0.11 points

with a 95 percent confidence interval of:

Minus 0.15 to minus 0.08.

That result was statistically significant.

However, there is an important distinction between statistical significance and clinical significance.

A 0.11 point change on a pain scale is relatively small.

The authors themselves later acknowledge that the overall effect on VAS pain was modest.

That means probiotics should not be viewed as a powerful painkiller based on these results.

The more interesting story may be what happened to inflammation.

WOMAC Pain Improved Too

Researchers also examined WOMAC pain scores.

WOMAC stands for the Western Ontario and McMaster Universities Osteoarthritis Index and is commonly used to measure osteoarthritis symptoms.

Two trials involving 268 participants found that probiotics significantly improved WOMAC pain scores.

The average difference was:

Minus 2.48 points

with a 95 percent confidence interval from:

Minus 4.55 to minus 0.40.

However, heterogeneity was extremely high at 91 percent.

That means the results differed considerably between the two studies.

So although the pooled result favored probiotics, we should have less confidence that every probiotic intervention will produce the same effect.

Knee Stiffness Improved

Probiotics also appeared to reduce knee stiffness.

Across two trials involving 268 participants, WOMAC stiffness scores improved significantly.

The mean difference was:

Minus 0.26 points

with a 95 percent confidence interval from:

Minus 0.35 to minus 0.17.

The researchers considered the improvement potentially clinically meaningful when compared with previously established minimal clinically important difference ranges for stiffness.

This could matter because stiffness is one of the most frustrating symptoms of osteoarthritis, particularly after sitting for long periods or first thing in the morning.

Overall WOMAC Scores Improved

The researchers also found a statistically significant reduction in total WOMAC scores.

Across two trials, the pooled improvement was approximately:

13.16 points.

The authors noted that this magnitude falls within previously proposed ranges for clinically meaningful improvement.

However, once again, the result came from only two studies and there was considerable variation between trials.

This is promising evidence.

It is not definitive evidence.

Physical Function Did Not Significantly Improve

Here is where the findings become more nuanced.

Even though participants reported improvements in pain and stiffness, probiotics did not significantly improve WOMAC physical function.

The pooled result was:

Mean difference: minus 10.16

but the confidence interval crossed zero and the p value was:

0.08

meaning the result did not meet the traditional threshold for statistical significance.

Why would pain and stiffness improve without a clear improvement in physical function?

The authors offer one explanation.

Probiotics may primarily affect inflammation and symptoms, while meaningful improvements in physical function may require changes in:

  • Muscle strength
  • Joint structure
  • Cartilage
  • Movement patterns
  • Physical conditioning

And those adaptations may take much longer than the 8 to 24 week interventions used in these trials.

That reinforces an important point:

Probiotics would not replace exercise or physical therapy for knee osteoarthritis.

If they have a role, it is more likely as an additional tool rather than a standalone treatment.

One of the Most Interesting Findings Involved Inflammation

Researchers pooled four studies involving approximately 350 participants that measured C reactive protein.

C reactive protein, commonly abbreviated CRP, is a marker of systemic inflammation.

Probiotic supplementation significantly reduced CRP.

The mean difference was:

Minus 1.08

with a 95 percent confidence interval from:

Minus 1.73 to minus 0.42.

The result was highly statistically significant.

But there was also very high heterogeneity at 94 percent.

Again, that means different studies produced substantially different responses.

What caused the variation?

The researchers found an interesting clue.

People With More Inflammation May Benefit More

When participants were divided according to their baseline inflammatory or metabolic burden, the effect on CRP differed.

In people with a higher inflammatory burden, probiotics reduced CRP by approximately:

1.76

compared with approximately:

0.53

in people with more typical inflammatory levels.

This raises an interesting possibility.

People with greater systemic inflammation may have more room to benefit from strategies that influence gut mediated inflammatory pathways.

However, this was a subgroup finding and should be considered exploratory.

It is far too early to recommend probiotics based on someone's CRP level alone.

Not All Probiotics Worked the Same

This may be the most practically important finding in the entire review.

A probiotic is not one ingredient.

Different bacterial and yeast strains have different biological effects.

The review found substantial differences among strains.

Saccharomyces boulardii

Saccharomyces boulardii produced the strongest improvement in WOMAC pain among the strains evaluated.

The reported mean difference was:

Minus 3.57

with a 95 percent confidence interval from:

Minus 4.66 to minus 2.49.

Interestingly, S. boulardii is technically a beneficial yeast rather than a bacterium.

The authors propose that it may influence osteoarthritis symptoms partly by improving intestinal barrier integrity and reducing movement of inflammatory bacterial products into circulation.

LatiLactobacillus sakei LB P12

LatiLactobacillus sakei LB P12 showed a broader combination of effects.

Researchers reported improvements in:

  • WOMAC total score
  • VAS pain
  • IL 1 beta

The strain appeared particularly interesting because it may influence short chain fatty acid production and the NF kappa B inflammatory pathway.

Bifidobacterium infantis BX 01

Bifidobacterium infantis BX 01 also produced improvements in both symptoms and inflammation.

The review reported:

VAS pain: minus 2.11

and

hs CRP: minus 1.89.

Lactobacillus casei Shirota

The researchers also identified Lactobacillus casei Shirota as another promising strain.

In their strain specific analysis, it was associated with favorable changes in pain and total WOMAC scores with relatively low heterogeneity.

Potential mechanisms include effects on regulatory T cells, which help regulate inflammatory immune responses.

Why Strain Specificity Matters

This is an important lesson whenever we discuss probiotics.

You cannot assume that research on one strain applies to every probiotic supplement.

Think about probiotics more like medications than vitamins.

Two bacterial strains may belong to the same general genus but still have very different biological effects.

The review found that variation in:

  • Probiotic strain
  • Dosage
  • Treatment duration
  • Disease severity
  • Baseline inflammation

contributed substantially to differences between studies.

So buying a random probiotic labeled "50 billion CFU" does not mean you are necessarily reproducing the results of these clinical trials.

The strain matters.

The Gut Joint Axis Explained

So how could microorganisms living in your intestines possibly affect cartilage in your knee?

Researchers propose several interconnected mechanisms.

1. A Stronger Intestinal Barrier

Some probiotics may improve intestinal barrier function.

A stronger barrier could reduce the movement of bacterial products such as LPS from the intestines into circulation.

Less exposure to those compounds may mean less activation of inflammatory immune pathways.

2. Immune Regulation

Certain probiotic strains may influence regulatory T cells and other immune cells.

These changes could help create a less inflammatory systemic environment.

For example, the authors note that Lactobacillus casei Shirota may encourage differentiation of regulatory T cells.

3. Short Chain Fatty Acids

Gut bacteria produce compounds known as short chain fatty acids, or SCFAs, when they ferment certain dietary fibers.

Some SCFAs can influence inflammatory signaling.

The authors discuss research suggesting LatiLactobacillus sakei LB P12 may influence SCFA production, which could help down regulate NF kappa B signaling.

4. Reduced Cartilage Degrading Signals

NF kappa B helps regulate inflammatory molecules and enzymes including MMP 13.

MMP 13 contributes to cartilage matrix degradation.

If probiotic driven changes in gut metabolites reduce these inflammatory signals, they could theoretically slow some of the inflammatory processes affecting cartilage.

That is an exciting hypothesis.

But this meta analysis does not prove that probiotics preserve cartilage or slow structural osteoarthritis progression.

Do Probiotics Actually Rebuild Cartilage?

No evidence from this review demonstrates that.

That distinction is important.

Most of the positive outcomes involved:

  • Pain
  • Stiffness
  • Inflammatory markers

Physical function did not significantly improve overall, and the included trials were relatively short.

The authors specifically note that probiotics appear more likely to affect inflammation and symptoms rather than joint structure.

So claims that probiotics "regrow cartilage" or "reverse arthritis" would go well beyond the evidence.

Were Probiotics Safe?

The safety findings were reassuring.

Across all eight randomized trials involving 1,129 participants, there was no significant difference in adverse events between probiotics and placebo.

The risk ratio was:

0.71

with a 95 percent confidence interval of:

0.23 to 2.18.

The p value was:

0.55.

The authors reported no major safety signal.

That makes probiotics interesting as a potential complementary therapy because their risk profile appears relatively favorable in the populations studied.

However, probiotics are not appropriate for absolutely everyone, particularly some severely immunocompromised individuals, and people with significant medical conditions should discuss supplementation with their healthcare provider.

How Long Were Probiotics Taken?

Most interventions lasted approximately:

12 weeks to 6 months.

This is another useful practical takeaway.

These studies were not testing whether taking a probiotic for three days makes knee pain disappear.

If probiotics influence osteoarthritis symptoms through changes in the microbiome and systemic inflammation, those effects would reasonably be expected to take time.

Consistency may therefore matter more than immediate timing.

Probiotics Should Not Replace Exercise

This deserves emphasis.

Exercise remains one of the most important tools for managing knee osteoarthritis.

Strengthening the muscles around the knee can improve joint stability, function, and the ability to perform everyday activities.

Regular movement also supports:

  • Cardiovascular health
  • Body weight management
  • Muscle mass
  • Mobility
  • Insulin sensitivity
  • Overall inflammatory health

The lack of a statistically significant improvement in physical function in this meta analysis is a useful reminder that simply reducing inflammation is not enough.

Better function usually requires using and strengthening the joint.

A probiotic, if beneficial, should be thought of as a potential addition to exercise and evidence based osteoarthritis management.

Not a replacement for them.

The Findings Are Promising, but the Evidence Is Still Weak

There is an important tension in this paper.

The pooled results look promising.

But the authors repeatedly emphasize that there are not yet enough high quality trials to make strong clinical recommendations.

Only eight randomized controlled trials qualified for inclusion.

Several outcomes were based on only two studies.

Studies used different probiotic strains.

Doses differed.

Intervention durations differed.

Participants had different disease severities.

Baseline inflammatory status differed.

And several pooled outcomes had extremely high heterogeneity.

The authors explicitly caution that the positive symptom findings should not yet be treated as definitive proof of efficacy.

That is probably the single most important caveat in the paper.

Important Limitations

The study has several limitations.

First, only eight randomized trials were available.

That limits statistical power and makes publication bias difficult to assess reliably.

Second, some strain specific conclusions were based on individual studies.

A single promising trial is not enough to establish that a particular strain reliably treats knee osteoarthritis.

Third, many results showed high heterogeneity.

For example:

WOMAC pain heterogeneity: 91 percent

Physical function: 96 percent

CRP: 94 percent.

Those numbers show that the studies did not all produce similar effects.

Fourth, the interventions were relatively short.

The trials do not tell us whether probiotics alter osteoarthritis progression over several years.

Finally, some studies combined probiotics with glucosamine, physical therapy, calcium, chondroitin, or other treatments, making interpretation more complicated.

What Should Future Studies Test?

The authors recommend larger and longer randomized trials.

They specifically highlight the need for more research on promising strains such as:

  • Lactobacillus casei Shirota
  • Bifidobacterium infantis BX 01

They also recommend using microbiome sequencing and metabolomics to determine how different strains actually change the gut environment.

Future studies may also help identify which patients respond best according to factors such as:

  • Age
  • Disease severity
  • Baseline gut microbiome
  • Inflammatory status
  • Body weight
  • Metabolic health

Eventually, probiotic recommendations for osteoarthritis may become highly individualized rather than simply recommending "a probiotic."

Simply Good Tip

If you are considering probiotics for general gut health or potentially as part of a broader joint health strategy, pay attention to the strain, not just the total CFU number on the label.

This study showed clearly that different probiotic strains produced different outcomes.

And do not forget that the gut microbiome also depends heavily on what you feed it.

A diet rich in diverse plant foods and fermentable fibers provides substrates that beneficial gut bacteria can use to produce short chain fatty acids.

Think of the combination this way:

Probiotics provide beneficial microorganisms.

Prebiotic fibers help feed beneficial microorganisms.

For long term gut health, the overall dietary environment may matter just as much as the bacteria inside a capsule.

The Bottom Line

Could probiotics help knee osteoarthritis?

Possibly.

This 2026 systematic review and meta analysis of eight randomized controlled trials found that probiotic supplementation was associated with improvements in:

  • VAS pain
  • WOMAC pain
  • Knee stiffness
  • Total WOMAC scores
  • C reactive protein

Probiotics did not significantly improve physical function overall, and the magnitude of some benefits was relatively small.

The study also suggests that the specific strain matters.

Saccharomyces boulardii, LatiLactobacillus sakei LB P12, Bifidobacterium infantis BX 01, and Lactobacillus casei Shirota all produced interesting results in individual analyses.

Perhaps most importantly, the findings add to growing interest in the gut joint axis.

Your knee is not an isolated piece of cartilage.

Joint inflammation exists within a much larger biological system involving metabolism, immune function, diet, body composition, and potentially the trillions of microorganisms living in your digestive tract.

We are not yet at the point where probiotics should be considered a proven treatment for knee osteoarthritis.

But the idea that improving gut health could potentially influence joint symptoms is becoming increasingly difficult to dismiss.

For now, probiotics appear most appropriately viewed as a promising complementary strategy that deserves more research, while exercise, strength training, weight management when needed, and evidence based medical care remain the foundations of knee osteoarthritis management.

References

  1. Chen K, Sun Y, Cui L, Zhu Y, Zhang B, Wu L. Effectiveness and Safety of Probiotics in Treating Knee Osteoarthritis: An Updated Systematic Review and Meta Analysis of Randomized Controlled Trials. Frontiers in Medicine. 2026;13:1799943.
  2. Wang X, Wu Y, Liu Y, et al. Altered gut microbiome profile in patients with knee osteoarthritis. Frontiers in Microbiology. 2023;14:1153424.
  3. Amin U, Jiang R, Raza SM, et al. Gut joint axis: Oral probiotic ameliorates osteoarthritis. Journal of Traditional and Complementary Medicine. 2024;14:26 to 39.
  4. Song M, Kim WJ, Shim J, Song K. LatiLactobacillus sakei LB P12 ameliorates osteoarthritis by reducing cartilage degradation and inflammation via regulation of the NF kappa B/HIF 2 alpha pathway. Journal of Microbiology and Biotechnology. 2025;35.
  5. Ferrillo M, Giudice A, Migliario M, et al. Oral gut microbiota, periodontal diseases, and arthritis: Literature overview on the role of probiotics. International Journal of Molecular Sciences. 2023;24:4626.

Frequently Asked Questions

Can probiotics help knee arthritis pain?

This meta analysis found statistically significant improvements in both VAS and WOMAC pain measures. However, the size of the average VAS improvement was small, and results varied among probiotic strains and studies.

Can probiotics reduce inflammation from osteoarthritis?

Four trials found a significant reduction in C reactive protein with probiotics. The response varied considerably among studies, and people with a higher baseline inflammatory burden appeared to experience greater reductions.

What is the gut joint axis?

The gut joint axis describes the potential relationship between the intestinal microbiome, intestinal barrier, immune system, systemic inflammation, and joint health. Researchers hypothesize that changes in gut bacteria can influence inflammatory signaling that ultimately affects joints.

Which probiotic is best for knee osteoarthritis?

There is not enough evidence to recommend one definitive strain. Saccharomyces boulardii, LatiLactobacillus sakei LB P12, Bifidobacterium infantis BX 01, and Lactobacillus casei Shirota produced promising findings, but many strain specific results come from only one or a few trials.

How long did people take probiotics?

Most studies lasted roughly 12 weeks to six months, so the research does not suggest probiotics work immediately.

Do probiotics rebuild knee cartilage?

This review does not establish that probiotics rebuild cartilage or reverse osteoarthritis. Their observed benefits were primarily related to pain, stiffness, and inflammatory markers, while physical function did not significantly improve overall.

Are probiotics safe for people with knee osteoarthritis?

Across eight trials involving 1,129 participants, adverse events were not significantly different between probiotics and placebo, suggesting generally good tolerability in the populations studied.

Back to top